Z-100

DRUG3 trials

Sponsors

Zeria Pharmaceutical

Conditions

Cervical CancerHIV Infections

Phase 1

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

TerminatedNCT00016692

Zeria PharmaceuticalHIV Infections

Updated: 2006-04-27

Phase 3

Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

CompletedNCT02247232

Zeria PharmaceuticalCervical Cancer

Start: 2014-12-31End: 2022-02-25Updated: 2022-03-04

Trial to Optimally Show the Pharmacological Action of Z-100

CompletedNCT03476018

Zeria PharmaceuticalCervical Cancer

Start: 2018-04-02End: 2021-12-10Updated: 2022-06-16